AFM
YARW

Anson Funds Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Anson Funds Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
49,724
+24,236
+95% +$707K 0.07% 112
2025
Q4 		$739K Buy
+25,488
New +$512K 0.07% 100

Other funds holding YARW

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Anson Funds Management's YARW Position: Q1 2026 in Review

Anson Funds Management increased its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 95% in Q1 2026, buying an estimated $707K and bringing the position to 49,724 shares worth $1.49M. The position accounts for 0.07% of the portfolio, ranked #112.

Anson Funds Management first reported a position in YARW in Q4 2025 and has held it in 2 quarters since. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Anson Funds Management held 49,724 shares of Yarrow Bioscience, Inc. Common Stock worth $1.49M as of Q1 2026.
  • Anson Funds Management bought 24,236 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $707K.
  • Yarrow Bioscience, Inc. Common Stock made up 0.07% of Anson Funds Management's portfolio in Q1 2026, its #112 holding.
  • Anson Funds Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q4 2025 and has held it in 2 quarters since.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Anson Funds Management's 13F filing for Q1 2026, filed 14 May 2026.